All enrolled patients who received at the very least a single dose of zosuquidar or placebo for the duration of induction have been monitored for your occurrence of adverse events (439 people, 219 on zosuquidar and 210 on placebo). The most typical adverse situations were being connected with the period https://georgeh544teo6.myparisblog.com/profile